Bausch Health Cos., Inc., formerly known as Valeant Pharmaceuticals International, is a pharmaceutical company founded in 1959 and headquartered in Quebec, Canada.

The studies discussed here provide a foundation for the development of novel approaches to improve the efficacy of cancer immunotherapy.

Delandistrogen moxeparvovec, also known as SRP-9001, trade name ELEVIDYS, is a kind of Adeno-associated virus gene therapy targeting micro dystrophin.

Sumitomo Pharma Co., Ltd. is a pharmaceutical organization based in Osaka-fu, Japan. It was founded in 1984 and has since been actively involved in the field of biomedicine.

Grifols SA is a pharmaceutical organization based in Spain that was founded in 1940. The company has a diverse portfolio of drugs targeting various therapeutic areas.

The current research focus of the drug is to evaluate the efficacy of the drug in patients with severe autoimmune diseases.

Fresenius SE & Co. KGaA is a pharmaceutical organization that was founded in 1912 and is based in Hessen, Germany.

Exosomes, a subpopulation of EVs, are small vesicles produced naturally by cells that play a role in intercellular communication.

Les Laboratoires Servier SAS is a pharmaceutical organization based in France that was founded in 1954.

Shanghai Pharmaceuticals Holding Co., Ltd. is a pharmaceutical organization based in Shanghai, China. It was founded in 1994 and has since become a prominent player in the biomedicine industry.

Vorolanib is a new generation of multi target kinase inhibitors with a completely new chemical structure.

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company that was founded in 1992 and is headquartered in Connecticut, United States.